Healthtech Startups

Pharmaron provides drug research and development services globally, supporting the discovery and development of pharmaceutical therapies through integrated capabilities across multiple geographic regions.

1 investor

Zylox-Tonbridge Medical is a Chinese medical device company developing clinical solutions and products, with a focus on neurovascular and peripheral vascular interventional treatments. It is publicly listed on the Hong Kong Stock Exchange (02190.HK).

1 investor

WeDoctor operates an online healthcare platform in China offering medical consultations, Q&A with doctors, and sale of pharmaceuticals and medical devices through licensed third-party e-commerce services. It provides patients with health information and online access to physicians across a wide range of medical specialties.

1 investor

Shenzhen-based medical device company developing active energy-based intravascular intervention devices, with a focus on laser technology for precision treatment of conditions such as varicose veins, coronary heart disease, and peripheral vascular disease. It serves the global medical market with innovative interventional medical equipment.

1 investor

MagAssist develops a multi-organ support platform for cardiac and critical care, starting from heart failure treatment. Its pipeline includes an extracorporeal fully magnetically-levitated artificial heart, a minimally invasive interventional artificial heart, a next-generation ECMO (extracorporeal membrane oxygenation) system, and a warm-blood organ transport platform.

1 investor

Endovastec (心脉医疗) develops and manufactures aortic and peripheral vascular interventional medical devices, including aortic stent systems used in clinical treatment. The company operates in China with a smart manufacturing facility in Shanghai's Pudong district.

1 investor

Kousai (恒赛生物), founded in 2018, is a Chinese biotech company developing and commercializing therapeutic dendritic cell (DC) vaccines for conditions such as relapsed/refractory tumors, chronic viral infections, and autoimmune diseases. It operates the Eco-DCVax platform and its lead pipeline candidate targets EBV-associated hematological and solid tumors.

1 investor

Atom Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule therapies for chronic gout, acute gout, and hyperuricemia. Its lead candidate ABP-671 is in multicenter Phase 2b/3 trials worldwide, including the US.

1 investor

日本エマージェンシーアシスタンス (EAJ) is a Japan-based company providing medical assistance services internationally, including emergency medical support, travel assistance, and security assistance services for customers worldwide. The company also operates as a concierge service provider and offers crisis management services for international students.

1 investor

StarCare Tech develops ECG (electrocardiogram) algorithms, including cloud-based and embedded-system algorithms, along with an ECG database, and offers remote ECG interpretation services and advisory services for healthcare companies.

1 investor

Jingze (Jingze Biopharmaceutical) is a Chinese biopharmaceutical company developing drug candidates focused on assisted reproduction and ophthalmology. Its pipeline includes eight candidate drugs, three of which are in late-stage development.

1 investor

aceRNA Technologies develops therapies based on RNA technology, focusing on the discovery of new functions of miRNA to contribute to regenerative medicine and the creation of new drugs for diseases that currently lack treatments. The company operates in the biotech and drug discovery field.

1 investor

Amidex develops Amidex®, a digital index (template) system for composite resin dental treatment that lets dentists restore and reshape teeth with minimal cutting of healthy tooth structure. The company targets dental clinics, aiming to standardize low-invasive restorative dentistry across Japan.

1 investor

Arktus Therapeutics develops regenerative medicine treatments derived from iPS cells, initially focusing on knee joint diseases with plans to expand to additional organ systems. The company brings together clinical, research, and regulatory expertise to advance innovative cell-based therapeutic products.

1 investor

Ayumo develops a gait analysis device designed by orthopedic physicians to support people with walking difficulties in receiving early appropriate treatment and improving motor function.

1 investor

A medical technology platform that provides comprehensive solutions for healthcare facilities, including AI-powered appointment systems, electronic medical records, and online consultation services. The company targets medical institutions in Japan and focuses on operational optimization and patient engagement.

1 investor

eWeLL is a Japanese company that develops iBow, an IT platform for home-visit nursing operations. It provides electronic medical record and management software for home nursing care providers.

1 investor

exmore builds AI products and digital transformation services for healthcare institutions in Japan, including an AI chatbot that answers patient inquiries and support for recruitment and back-office tasks. The company aims to reduce the operational burden on medical staff so they can focus on patient care.

1 investor

Forema is a Japanese company working on gut microbiome analysis and lactic acid bacteria strains, including a beta microbiome analysis service for children with autism and proprietary bacterial strains. It also operates retail and other product initiatives related to these offerings.

1 investor

GENOVA is a Japanese company headquartered in Tokyo with branches across Japan and a subsidiary in China. The page presents corporate information including offices, leadership, and group companies, but gives limited detail on its specific products or services.

1 investor

HikariQ Health develops innovative immunoassay methods and antibody therapeutics using proprietary Q-body technology, a fluorescence quenching-based antibody modification technique. The company targets pharmaceutical and medical applications to improve healthcare diagnostics and therapeutics globally.

1 investor

I.W.G develops AI technology for healthcare data platforms that enable diagnostic support and data sharing in medical settings. The company works with international healthcare institutions on medical digital transformation solutions.

1 investor

IMPUTE develops digital therapy solutions for children with autism spectrum disorder, ADHD, and learning disabilities. The platform assesses individual needs and provides digital therapeutic treatments to support cognitive development.

1 investor

KOEDA develops a 1mm anchor device that is inserted through an endoscopic ultrasound puncture needle to fix the gallbladder and stomach/duodenum together, making EUS-guided gallbladder drainage (EUS-GBD) easier and safer for treating conditions such as acute cholecystitis. The Japan-based medical device startup targets gastroenterology and endoscopy clinicians and is developing its technology through animal studies and clinical trials.

1 investor